Home The crystal structure of (E)-N′-(1-(4-fluorophenyl)propylidene)-2-hydroxybenzohydrazide, C16H15FN2O2
Article Open Access

The crystal structure of (E)-N′-(1-(4-fluorophenyl)propylidene)-2-hydroxybenzohydrazide, C16H15FN2O2

  • Sha Yang , Jing Men and Wenqiang Tang ORCID logo EMAIL logo
Published/Copyright: April 6, 2023

Abstract

C16H15FN2O2, monoclinic, P21/c (no. 14), a = 9.2751(7) Å, b = 13.1232(7) Å, c = 11.7155(8) Å, β =  90.011 ( 7 ) , V = 1426.00(16) Å3, Z = 4, R g t (F) = 0.0570, w R r e f (F 2) = 0.1462, T = 293 K.

CCDC no.: 2251418

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.46 × 0.43 × 0.37 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.10 mm−1
Diffractometer, scan mode: Bruker D8 Venture, φ and ω
θ max, completeness: 29.4°, >99%
N(hkl)measured, N(hkl)unique, R int: 11,714, 3392, 0.025
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 2448
N(param) refined: 193
Programs: Bruker [1], SHELX [2, 3], Olex2 [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 1.0138 (3) 0.47461 (19) 0.74180 (18) 0.0621 (6)
C2 0.8893 (3) 0.43123 (16) 0.70312 (18) 0.0641 (6)
H2 0.860663 0.367323 0.728896 0.077*
C3 0.8067 (2) 0.48401 (15) 0.62506 (17) 0.0547 (5)
H3 0.722544 0.454800 0.596918 0.066*
C4 0.84766 (19) 0.58012 (13) 0.58804 (15) 0.0447 (4)
C5 0.9741 (2) 0.62134 (16) 0.63075 (17) 0.0580 (5)
H5 1.002600 0.686048 0.607547 0.070*
C6 1.0590 (2) 0.56774 (18) 0.70754 (19) 0.0660 (6)
H6 1.144805 0.595135 0.734801 0.079*
C7 0.7588 (2) 0.63509 (13) 0.50206 (15) 0.0441 (4)
C8 0.7567 (2) 0.75048 (14) 0.50179 (16) 0.0526 (5)
H8A 0.658952 0.773642 0.488052 0.063*
H8B 0.785808 0.774961 0.576452 0.063*
C9 0.8548 (3) 0.79586 (18) 0.4128 (2) 0.0767 (7)
H9A 0.825323 0.773114 0.338454 0.115*
H9B 0.952155 0.774540 0.426907 0.115*
H9C 0.849287 0.868846 0.416217 0.115*
C10 0.54761 (19) 0.57292 (12) 0.26588 (15) 0.0427 (4)
C11 0.46200 (18) 0.62964 (12) 0.17896 (14) 0.0398(4)
C12 0.3931 (2) 0.57202 (14) 0.09568 (17) 0.0538(5)
H12 0.402777 0.501499 0.097119 0.065*
C13 0.3110 (2) 0.61596 (17) 0.01124(18) 0.0648(6)
H13 0.265243 0.575751 −0.043187 0.078*
C14 0.2975 (2) 0.72066 (16) 0.00852 (17) 0.0608 (6)
H14 0.242352 0.751136 −0.048322 0.073*
C15 0.3643 (2) 0.78005 (14) 0.08844 (16) 0.0521 (5)
H15 0.354330 0.850520 0.085530 0.063*
C16 0.44699 (18) 0.73583 (12) 0.17398 (15) 0.0422 (4)
F1 1.09534 (17) 0.42254 (12) 0.81874 (13) 0.0963 (5)
N1 0.60765 (16) 0.62681 (10) 0.35036 (12) 0.0454 (4)
H1 0.595414 0.691702 0.353578 0.055*
N2 0.68935 (16) 0.57799 (10) 0.43243 (12) 0.0444 (4)
O1 0.56368 (17) 0.48054 (9) 0.25904 (13) 0.0685 (5)
O2 0.51725 (17) 0.79355 (9) 0.25231 (12) 0.0629 (4)
H2A 0.493628 0.853386 0.244749 0.094*

1 Source of materials

A single crystal of (E)-N′-(1-(4-fluorophenyl) propylidene)-2-hydroxybenzohydrazide was synthesized through a facile method. Initially, salicyl hydrazide (0.15 g, 1 mmol) and 4′-fluoropropiophenone (0.15 g, 1 mmol) were dissolved in 25 mL of absolute alcohol in a round-bottom flask equipped with a stir bar and rubber septum. The mixture was further treated with five drops of glacial acetic acid and stirred for 10 min at 60 °C. Following the addition of acetic acid, the reaction mixture turned yellowish, and stirring was continued for 6 h at the same temperature. The solvent was then evaporated to dryness using a rotary evaporator, yielding the crude product that was then purified to obtain a single crystal of high quality. For crystal growth, the crude product was dissolved in a minimal amount of hot ethanol and slowly cooled to room temperature.

2 Experimental details

The Direct Methods implemented in SHELXT [2] were utilized in order to solve the crystal structure, and it was further refined using the SHELXL program [3]. All hydrogen atoms were placed at calculated positions and refined isotropically. Finally, the OLEX2 software package [4] was employed for generating the graphical representation of the crystal structure.

3 Comment

The N-acylhydrazone moiety has gained considerable attention in the development of biologically active compounds, making it a promising structural motif for drug discovery [5]. An essential step in understanding the properties and behavior of organic compounds is the preparation and study of single crystal structures [6]. Herein, we report the single crystal structure of (E)-N′-(1-(4-fluorophenyl)propylidene)-2-hydroxybenzohydrazide, which provides significant insights into its molecular structure and packing arrangement.

There is one molecule in the asymmetric unit (see the figure). In terms of molecular geometry, the bond lengths and angles were found to be consistent with those that are typically observed for similar compounds. Notably, the C–N bond length was determined to be 1.338(3) Å, while the C=N bond length was observed to be 1.281(3) Å, indicating the presence of partial single and double bond character [7], [8], [9], [10]. The angles between the C7–N2–N1 and C10–N1–N2 atoms were measured to be 116.58 ( 14 ) and 119.86 ( 14 ) , respectively, and these values fell within the ranges of what is typically observed in similar chemical systems [11, 12].

The crystal structure of (E)-N′-(1-(4-fluorophenyl) propylidene)-2-hydroxybenzohydrazide displays a complex three-dimensional network of hydrogen bonds, which involve the carbonyl oxygen and amide nitrogen atoms. The crystal structure is composed of layers of molecules, and the hydrogen bonds (N1–H1⋯O2 and O2–H2A⋯O1) facilitate the cohesion of these layers.

The investigation of the crystal structure of 1-(2-chlorophenyl)-3-cycloheptylurea can contribute to a better understanding of the structure-property relationships in similar derivatives [13, 14].


Corresponding author: Wenqiang Tang, Collaborative Innovation Center of Green Manufacturing Technology for Traditional Chinese Medicine in Shaanxi Province, School of Pharmacy, Shaanxi Institute of International Trade & Commerce, Xi’an, China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Natural Science Foundation of Shaanxi Province (2021JQ-883), The Key Breeding Program by the Collaborative Innovation Center of Green Manufacturing Technology for Traditional Chinese Medicine in Shaanxi Province (2019XT-1-02), Effective Substances of Traditional Chinese Medicine Innovative Team in Shaanxi Institute of International Trade & Commerce (SSY18TD01), and Key Laboratory of Molecular Imaging and Drug Synthesis of Xianyang City (2021QXNL-PT-0008).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8.10.1107/S2053273314026370Search in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

5. Zhang, B., Zhao, Y., Zhai, X., Wang, L., Yang, J., Tan, Z., Gong, P. Design, synthesis and anticancer activities of diaryl urea derivatives bearing N-acylhydrazone moiety. Chem. Pharm. Bull. 2013, 60, 1046–1054; https://doi.org/10.1248/cpb.c12-00234.Search in Google Scholar PubMed

6. Ajayeoba, T. A., Woods, J. O., Ayeni, A. O., Ajayi, T. J., Akeem, R. A., Hosten, E. C., Akinyele, O. F. Synthesis, crystallographic, computational and molecular docking studies of new acetophenone-benzoylhydrazones. J. Mol. Struct. 2021, 1237, 130275; https://doi.org/10.1016/j.molstruc.2021.130275.Search in Google Scholar

7. Wang, X.-S., Sheng, J., Lu, L., Yang, K., Li, Y.-L. Combinatorial synthesis of 3-arylideneaminoquinazolin-4(1H)-one derivatives catalyzed by iodine in ionic liquids. ACS Comb. Sci. 2011, 13, 196–199; https://doi.org/10.1021/co1000713.Search in Google Scholar PubMed

8. Sreeja, P. B., Sithambaresan, M., Aiswarya, N., Kurup, M. R. P. N′-[(E)-2-Fluorobenzylidene]benzohydrazide. Acta Crystallogr. 2013, E69, o1828; https://doi.org/10.1107/s1600536813031747.Search in Google Scholar PubMed PubMed Central

9. Sivajeyanthi, P., Jeevaraj, M., Edison, B., Balasubramani, K. Crystal structure and Hirshfeld surface analysis of (E)-4-amino-N′-[1-(4-methylphenyl)ethylidene]benzohydrazide. Acta Crystallogr. 2017, E73, 1029–1032; https://doi.org/10.1107/s205698901700857x.Search in Google Scholar

10. Ding, Y.-W., Ni, L.-L. 4-Dimethylamino-N′-(3-pyridylmethylidene) benzohydrazide. Acta Crystallogr. 2010, E66, o2636; https://doi.org/10.1107/s1600536810037670.Search in Google Scholar

11. Mague, J. T., Mohamed, S. K., Akkurt, M., Potgieter, H., Albayati, M. R. 4-Chloro-N′-[(E)-2-chlorobenzylidene]benzohydrazide monohydrate. Acta Crystallogr. 2014, E70, o612; https://doi.org/10.1107/s1600536814008885.Search in Google Scholar

12. Xi-Shi, T., Yi-Min, F. 2-Hydroxy-N′-[1-(3-methylpyrazin-2-yl) ethylidene]benzohydrazide. Acta Crystallogr. 2008, E64, o707; https://doi.org/10.1107/s1600536808006697.Search in Google Scholar

13. Biswas, N., Bera, S., Sepay, N., Pal, A., Halder, T., Ray, S., Acharyya, S., Biswas, A. K., Drew, M. G. B., Ghosh, T. Simultaneous formation of non-oxidovanadium(iv) and oxidovanadium(v) complexes incorporating phenol-based hydrazone ligands in aerobic conditions. New J. Chem. 2020, 44, 3700–3716; https://doi.org/10.1039/c9nj06114b.Search in Google Scholar

14. Tang, C.-B. 2-Methyl-N′-[1-(2-pyridyl)ethylidene]benzohydrazide. Acta Crystallogr. 2011, E67, o271; https://doi.org/10.1107/s1600536810054267.Search in Google Scholar PubMed PubMed Central

Received: 2023-03-12
Accepted: 2023-03-24
Published Online: 2023-04-06
Published in Print: 2023-06-27

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of phenyl(3,3-dichloro-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one)methanone, C7H4Cl2N2O
  4. Crystal structure of poly[diaqua-bis(μ 2-1,4-diaminobutane-N:N′)cobalt(II)] dichloride, C8H28Cl2CoN4O2
  5. Synthesis and crystal structure of (4aR,7S)-7-hydroxy-7-isopropyl-1,1-dimethyldecahydro-2H,6H-8a,4a-(epoxymethano)phenanthren-12-one, C20H32O3
  6. The crystal structure of 1-(2-chlorobenzyl)-3-(3,5-dichlorophenyl)urea, C14H11Cl3N2O
  7. Crystal structure of tetrapropylammonium-1,3,5-thiadiazole-5-amido-2-carbamate – 1,2,4-thiadiazole-3,5-diamine – water (1/1/1), C17H37N9O3S2
  8. Tetrabutylammonium 1,3,5-thiadiazole-5-amido-2-carbamate—1,2,4-thiadiazole-3,5-diamine— water (1/1/1), C21H45N9O3S2
  9. The crystal structure of ((E)-2,4-dichloro-6-(((2-hydroxy-5-nitrophenyl)imino)methyl)phenolato-κ 3 N,O,O′)tris(pyridine-κN)manganese(II), C28H21Cl2MnN5O4
  10. The crystal structure of aqua-bis{2-bromo-6-((2-(2-phenylacetyl)hydrazineylidene)methyl)phenolato-κ3 N,O,O′}-dimethylformamide-κ1 O-erbium(III) chloride – dimethylformamide – water (1/2/1), C39H49N7O9Br2ClEr
  11. Crystal structure of (diaqua-bis(phenanthroline-K 2 N,N′)-tetrakis(m 2-3,4,5,6-tetrafluorophthalato-K 4 O,O:O′:O″;K 2 O:O′)dierbium (III) phenanthroline (1/2), C80H38Er2F16N8O18
  12. Crystal structure of (E)-7-methoxy-2-(4-methoxy-2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C20H17F3O3
  13. The crystal structure of 4–(4,4,5,5–tetramethyl–1,3,2–dioxaborolan–2–yl)morpholine, C10H20BNO3
  14. The crystal structure of catena–poly[aqua(1-naphthoato-κ 2 O,O′)-(μ-1-naphthoato-κ 4 O:O,O′:O′)lead(II)], C22H16O5Pb
  15. The crystal structure of 1-(4-chlorophenyl)-3-cycloheptylurea, C14H19ClN2O
  16. The crystal structure of 4-(pyren-1-yl)butyl-4-nitrobenzoate, C27H21NO4
  17. Crystal structure of cyclo-(bis(µ2-3,3′-(1H-imidazole-3-ium-1,3-diyl)dipropionato-κ4 O,O′:O″,O″′)-dinitrato-κ2 O,O′-tetraoxido-diuranium(VI) C18H22N6O18U2
  18. The crystal structure of catena-[nitrato-κ 2 O,O′-(μ 3-3-iodobenzene-1,2-dicarboxylato-κ 4 O:O′:O″,O‴)-(2,2′:6′,2″-terpyridine-κ 3 N,N′,N″)lanthanum(III)], C23H14IN4O7La
  19. Redetermination of crystal structure of [bis(pyridin-2-ylmethyl)amine-κ 3 N,,]chloridopalladium(II) chloride monohydrate
  20. Crystal structure of catena-poly[triaqua-[bis(m2-4-(1H-1,2,4-triazol-1-yl)benzoato-k2O:O')-(4-(1H-1,2,4-triazol-1-yl)benzoato-k1O)-praseodymium (III) monohydrate], C27H26N9O10Pr
  21. Crystal structure of trans-diaqua-bis(methyl methylcarbamohydrazonothioato-κ2 N,N′) nickel(II) iodide semihydrate, C6H22N6O2NiS2I2·0.5H2O
  22. The crystal structure of 2-(2-fluoro-4-methyl-5-((2,2,2-trifluoroethyl)thio)phenyl)isoindolin-1-one, C17H13F4NOS
  23. The crystal structure of di-μ-1-naphthylacetato-κ 3 O,O′:O;κ 3 O:O,O′-bis[(1-naphthylacetato-κ 2 O,O′)(2,2′-bipyridine-κ 2 N,N′)lead(II)] monohydrate, C68H54N4O9Pb2
  24. Crystal structure of tetrapropylammonium guanidinium 4,4′-sulfonyldibenzoate monohydrate, C27H44N4O7S
  25. Crystal structure of bis(tetrapropylammonium) terephthalate – 1-(diaminomethylene)thiourea – water (1/2/4) C18H40N5O4S
  26. Crystal structure of (E)-7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C21H20FNO2
  27. The crystal structure of poly[diaqua-bis(μ 3-5-bromobenzene-1,3-dicarboxylato-κ 3 O,O,O′)-(μ 2-1,3-bis-(4-pyridyl)-propane-κ 2 N,N′)-dizinc(II))] – 5-bromobenzene-1,3-dicarboxylic acid [2/1], C37H29Br3N2O14Zn2
  28. The crystal structure of 2-bromo-1,3-phenylene bis(4-methylbenzenesulfonate), C20H17BrO6S2
  29. Crystal structure of europium dichromium icosaaluminum, EuCr2Al20
  30. The crystal structure of N1,N3-di((E)-benzylidene) isophthalohydrazide dihydrate, C 22 H 22 N 4 O 4
  31. Crystal structure of 7α,11α-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
  32. Crystal structure of 4-chloro-N′-[(1E)-pyridin-3-ylmethylidene]benzohydrazide, C13H10ClN3O
  33. The crystal structure of (Z)-3-(1-(2-((E)-4-isopropylbenzylidene)hydrazinyl)ethylidene) chroman-2,4-dione, C21H20N2O3
  34. Crystal structure of E-7-fluoro-2-(2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C18H12F4O
  35. Crystal structure of bis(6-aminopyridine-2-carboxylato–k2O,N)-bis(N,N-dimethylformamide-k1 O)zinc(II), C18H24N6O6Zn
  36. Crystal structure of 5-(adamantan-1-yl)-3-[(4-{[2-(trifluoromethyl)phenyl]-methyl}piperazin-1-yl)methyl]-1,3,4-oxadiazole-2(3H)-thione, C25H31F3N4OS
  37. Crystal structure of tetrapropylammonium bicarbonate–1-(diaminomethylene)thiourea – water (2/2/1), C30H72N10O7S2
  38. Crystal structure of tris(2,2′-bipyridine-κ2 N,N′)iron(II) triiodide – dichloromethane (2/1), C61H50Cl2Fe2I12N12
  39. Crystal structure of 2-amino-3-[2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-ethylideneamino]-but-2-enedinitrile, C17H17N5
  40. The crystal structure of 1-(2-chlorophenyl)-3-cycloheptylurea, C14H19ClN2O
  41. Crystal structure of potassium bis(pentaselenido-κ 2 Se 1,Se 5)palladate(II), K2[Pd(Se5)2]
  42. The crystal structure of 5,10-bis(2-methoxyethyl)-5,10-dihydro-[1,2,3,4]tetrathiocino[5,6-b:8, 7-b′]diindole, C22H22N2O2S4
  43. The crystal structure of 4-(4-iodophenyl)-5H-1,2,3-dithiazole-5-thione, C8H4INS3
  44. Crystal structure of bis{μ2-(4-acetyl-phenoxy)acetato-κ2 O:O′}-bis{μ2-(4-acetyl-phenoxy)acetato-κ3 O,O′:O)- bis{(4-acetyl-phenoxy)acetato-κ2 O,O′}-bis(phenanthrolin-κ2 N,N′)didysprosium(III) tetrahydrate, C84H78N4O28Dy2
  45. Crystal structure of Eu2Pd3.37(1)Zn13.63(1)
  46. Crystal structure of 2-methoxy-4-(methoxy-carbonyl)phenyl 2-chloro-4-fluorobenzoate, C16H12ClFO5
  47. Crystal structure of catena-poly[bis(μ2-dicyanamide-κ2 N:N′)-bis(4-vinylpyridine-κN)-copper(II)], C18H14CuN8
  48. The crystal structure of iguratimod-dimethylformamide (1/1), C17H14N2O6S·C3H7NO
  49. Synthesis and crystal structure of 1-((3R,10S,13S,17S)-10,13-dimethyl-3-(m-tolylamino)hexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO
  50. The crystal structure of diaqua-bis(4-bromo-2-formylphenoxy)zinc(II), C14H12Br2O6Zn
  51. The crystal structure of tetra(1-ethylimidazole-κ 1 N)-[μ 4-imidazole-4,5-dicarboxylato-κ 4 O, N, O′, N′]-trioxido-divanadium, C25H33N10O7V2
  52. The crystal structure of (E)-N′-(1-(4-fluorophenyl)propylidene)-2-hydroxybenzohydrazide, C16H15FN2O2
Downloaded on 11.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0113/html?lang=en
Scroll to top button